These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8233098)

  • 21. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine.
    Simon GS; Dewey WL
    J Pharmacol Exp Ther; 1981 Aug; 218(2):318-23. PubMed ID: 7019415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats.
    Torres-López JE; Juárez-Rojop IE; Granados-Soto V; Diaz-Zagoya JC; Flores-Murrieta FJ; Ortíz-López JU; Cruz-Vera J
    Neuropharmacology; 2007 Mar; 52(3):788-95. PubMed ID: 17157334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial antinociceptive cross-tolerance to intracerebroventricular beta-endorphin in mice tolerant to systemic morphine.
    Tseng LF; Lin JJ; Collins KA
    Eur J Pharmacol; 1993 Sep; 241(1):63-70. PubMed ID: 8223926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive effect of L-arginine in diabetic mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Mar; 254(1-2):113-7. PubMed ID: 8206107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice.
    Ohsawa M; Nagase H; Kamei J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):780-7. PubMed ID: 9694934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathy.
    Yadlapalli JSK; Dogra N; Walbaum AW; Prather PL; Crooks PA; Dobretsov M
    Life Sci; 2018 Jan; 192():151-159. PubMed ID: 29191644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test.
    Dambisya YM; Lee TL
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):179-84. PubMed ID: 8046951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of protein phosphatases alters the expression of morphine tolerance in mice.
    Bernstein MA; Welch SP
    Eur J Pharmacol; 1998 Jan; 341(2-3):173-7. PubMed ID: 9543237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test.
    Sakurada T; Yogo H; Katsumata K; Tan-No K; Sakurada S; Kisara K; Ohba M
    Brain Res; 1994 Jun; 649(1-2):319-22. PubMed ID: 7525010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nitric oxide in diabetes-induced attenuation of antinociceptive effect of morphine in mice.
    Grover VS; Sharma A; Singh M
    Eur J Pharmacol; 2000 Jul; 399(2-3):161-4. PubMed ID: 10884515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of the type 1 inositol 1,4,5-trisphosphate receptor gene suppresses the morphine-induced antinociception in the mouse.
    Aoki T; Narita M; Ohnishi O; Mizuo K; Narita M; Yajima Y; Suzuki T
    Neurosci Lett; 2003 Oct; 350(2):69-72. PubMed ID: 12972155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
    Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressive effects of lamotrigine on the development and expression of tolerance to morphine-induced antinociception in the male mouse.
    Saberi M; Chavooshi B
    Brain Res; 2009 Sep; 1291():32-9. PubMed ID: 19615350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain.
    Narita M; Ioka M; Suzuki M; Narita M; Suzuki T
    Neurosci Lett; 2002 May; 324(2):97-100. PubMed ID: 11988336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.